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Acute massive pulmonary embolism after radiofrequency catheter ablation:
A rare complication after a common procedure
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Received December 30, 2010; accepted July 6, 2011AbstractA 41-year-old man received an electrophysiological study (EPS) and radiofrequency catheter ablation (RFCA) for atrioventricular reentrant
tachycardia (AVRT) in our hospital. Massive pulmonary embolism (PE) with hypotension developed 9 hours after these procedures. After
emergent pulmonary angiography and catheter-directed intrathrombus urokinase infusion and clot breaking, the patient recovered well. This case
suggests that life-threatening PE may occur in patients who receive EPS, RFCA, or both. An adequate observation time after RFCA and clinical
alertness are necessary for immediate diagnosis and treatment. Emergent catheter-directed therapy may be of benefit in some patients with acute
massive PE.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Radiofrequency catheter ablation (RFCA) is a common
procedure for the management of arrhythmias and is consid-
ered to be safe, with a major complication rate of 0.61%e3%
and a mortality rate of 0%e0.3%.1,2 The complication rate
was significantly higher in RFCA than in electrophysiologic
study (EPS) in a previous study (3.1% vs. 1.1%, respectively).3
Although pulmonary embolism (PE) is a rare complication of
RFCA,1e5 it can be fatal.2 Prompt diagnosis and management
can result in a good outcome.6 Herein, we report a case of
acute massive PE with shock, complicated by RFCA. The* Corresponding author. Dr. Tsu-Juey Wu, Cardiovascular Center, Taichung
Veterans General Hospital, 160, Section 3, Chung-Kang Road, Taichung 407,
Taiwan, ROC.
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http://dx.doi.org/10.1016/j.jcma.2011.07.002patient was successfully treated with catheter-directed phar-
macologic thrombolysis and clot breaking.
2. Case report
A 41-year-old man without any systemic diseases and
without past or family histories of thromboembolic events had
experienced intermittent palpitation for more than 20 years.
One month before admission, sudden onset of one episode
occurred while he was playing basketball. Electrocardiography
(ECG) showed a regular narrow QRS-complex tachycardia.
After admission, physical examination showed normal heart
sound without heart murmurs. There were no signs of deep
venous thrombosis (DVT). Echocardiography before EPS
showed normal left ventricle (LV) systolic wall motion and
minimal tricuspid regurgitation, with peak systolic pressure
gradient of 29.4 mmHg. For EPS, a coronary sinus (CS)
multipolar electrode catheter was introduced through a sheathhinese Medical Association. All rights reserved.
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electrode catheters were introduced through sheaths in the
right femoral vein and placed in the right atrium, the right
ventricle (RV), and the bundle of His. During EPS, ortho-
dromic atrioventricular reentrant tachycardia (AVRT) was
easily induced, with the earliest retrograde atrial activation
recorded at the distal CS electrode. Using a transaortic
approach via an 8-French sheath (Terumo Corp., Tokyo,
Japan) in the right common femoral artery, RFCAwas applied
over the anterior aspect of the mitral annulus, successfully
eliminating the accessory pathway. The total procedure time
was 95 minutes. The postprocedure echocardiogram was
unremarkable (i.e., no pericardial effusion or intra-cardiac
thrombus). The ECG showed normal sinus rhythm (Fig. 1A).
The punctured sites in the right inguinal area were manually
compressed for hemostasis, followed by a 3-kilogram sandbag
compression for 6 hours. The patient was observed under bed
rest condition in the cardiac care unit after EPS and RFCA.
Sudden onset of bradycardia with a heart rate of 40 beats per
minute (bpm) occurred 9 hours after the end of RFCA. Cold
sweating, drowsy consciousness, and involuntary movement of
bilateral arms were accompanied with blood pressure of 60/
30 mm Hg. The follow-up ECG (Fig. 1B) showed sinus rhythm
with a heart rate of 72 bpm; ST depression over V2 toV6, leads I
and II; T-wave inversion over V3 to V6, leads I, II, III, and aVF;
and an S1Q3T3 pattern. Emergent bedside echocardiogram
showedmarked dilatation of theRV.To rule out the possibility of
acute coronary syndrome, emergent coronary angiography
(CAG) was performed, and it showed normal coronary arteries.
However, pulmonary angiography revealed bilateralmassivePE
(Fig. 2A andB), especially on the right side (Fig. 2A). Urokinase
was first infused slowly via a 6-French Judkins Right 4 coronaryFig. 1. (A) The postprocedure electrocardiography (ECG) shows normal sinus rhydiagnostic catheter (Cordis Corp., Miami, FL) in the right
pulmonary artery. Afterwards, the catheter was advanced more
distally and inserted into a thrombus in the right upper pulmo-
nary artery. Catheter-directed therapy, including pharmacologic
thrombolysis with intrathrombus urokinase infusion and clot
breaking during catheter manipulation and rotation, was per-
formed. The pulmonary flowwas thereaftermuch improved (Fig
2C). A total of 300,000 IU of urokinase was given during the
above procedures. Further systemic intravenous urokinase,
180,000 IU/hour, was infused for 8 hours. Enoxaparin (60 mg,
subcutaneous injection, twice daily) was subsequently admin-
istered for 2 days. The medication was then shifted to warfarin
therapy (2.5 mg/day). This patient recovered well and was dis-
charged home 5 days later. Thrombophilic workup, including
anticardiolipin antibodies, homocysteine, antinuclear anti-
bodies, antithrombin-III, antiphospholipid antibodies, lupus
anticoagulant, protein S, proteinC, and cryoglobulin, all showed
negative findings. The patient took warfarin (2.5 mg/day) for 1
month and was event-free in the subsequent 6-month follow-up
period.
3. Discussion
Although PE complicated by RFCA was rare in previous
studies, with an incidence of 0%e0.25%,1e5 it can be life-
threatening2,6 and underestimated.7 Primm and others7 repor-
ted that 12% of patients had new perfusion defects detected by
ventilation-perfusion lung scans 1 day after right-heart cath-
eterization. This complication might be attributed to DVT of
the punctured femoral vein.4
Multiple venous sheaths inserted into a single femoral vein
are required in EPS or RFCA. Chen and colleagues8 reportedthm; (B) follow-up ECG shows acute ST-T changes with an S1Q3T3 pattern.
Fig. 2. Pulmonary angiography shows massive pulmonary embolism over the (A) right; and (B) left pulmonary arteries (marked by arrows); (C) thrombus over the
right upper pulmonary artery partially resolved, and the flow improved after catheter-directed therapy (marked by an arrow).
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a single femoral vein during RFCA, there was a high incidence
(19.2%) of nonocclusive DVT detected by duplex ultraso-
nography on the next day following ablation. But, none of
these patients with this complication experienced symptomatic
PE.8 In our patient, three sheaths were inserted into the right
femoral vein, ipsilateral to an 8-Frech femoral artery sheath. A
long-duration (6 hours) hemostasis procedure for the femoral
artery sheath may also compress the femoral vein simulta-
neously, leading to venous stasis. Both venous stasis and injury
of vascular endothelium caused by venous sheath placement
are believed to be the possible mechanisms for the formation
of DVT and subsequent PE.9 The application of heparinization
has been suggested for catheter manipulation during left-sided
RFCA in a North American Society of Pacing and Electro-
physiology policy statement.10 However, the use of heparin
should be individualized. In this particular case, systemic
heparinization was not applied because of a short procedure
time.
Although the time for PE to develop after RFCA varied
from 8.5 hours6 to 14 days,2 it has been suggested that same-
day home discharge after 4 to 6 hours of observation is safe for
uncomplicated RFCA.4 However, in patients with potential
risk for PE occurrence, a longer observation period after
RFCA may be needed. Alternatively, a follow-up duplex
ultrasonography before discharge, evaluating the thrombus
formation at the punctured femoral veins, may be appropriate
for the patients discharged under a “same-day home” policy.
Clinical alertness is important for the diagnosis and treat-
ment of PE complicated by RFCA. In this patient, emergent
follow-up ECG in shock state showed sinus rhythm with
a heart rate of 72 bpm, diffuse ST-T changes, and an S1Q3T3
pattern. Although he did not experience sinus tachycardia,
which is common in acute PE patients,11 the diagnosis of PE
could not be completely excluded because of the absence of
sinus tachycardia. Nevertheless, echocardiogram showed acute
RV dilatation, supporting the diagnosis of acute RV dysfunc-
tion and acute PE. The ST-T changes in ECG can occur both in
acute PE patients12 and in patients with acute coronary
syndrome. The latter possibility was excluded by an emergent
CAG.
Thrombolytic therapy reduced mortality in patients with PE
who were hemodynamically unstable.13 Interventionalcatheterization techniques (or so-called catheter-directed
therapy) for massive PE are the alternatives.14 They include
mechanical clot fragmentation/breaking and rheolytic throm-
bectomy, with intra-clot thrombolytic injection if needed.14
When compared with historical data of systemic thrombol-
ysis, catheter-directed therapy showed a better result, with
a success rate of 86.5% and a major complication rate of
2.4%.14 In our patient, catheter-directed intrathrombus phar-
macologic thrombolysis and clot-breaking during catheter
manipulation and rotation were performed. His hemodynamic
condition improved rapidly after these procedures.
In conclusion, although rare, PE may occur even in patients
receiving RFCA with a short procedure time. A longer
observation period after RFCA may be needed in patients with
potential risk for PE occurrence. Alternatively, duplex ultra-
sonography before discharge, determining the presence of
thrombus formation at the punctured femoral veins, may be
appropriate for those patients discharged under a “same-day
home” policy. Emergent catheter-directed therapy can provide
immediate improvement in patients with massive PE who are
hemodynamically unstable.
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